Trials / Completed
CompletedNCT05205434
Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Bitlis Eren University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Investigators aimed to evaluate the effectiveness of exercise programs given by synchronous and asynchronous telerehabilitation methods in patients after discharge from COVID-19.
Detailed description
Fifty seven participants will be enrolled. Participants will be randomly divided into 3 groups. For this purpose, patients will be recruited at the time of discharge from the hospital and two experimental groups with the same physical therapy and educational program will be carried out. participants in the control group will only educational program. Participants in experimental groups will be followed using videoconference interviews from synchronous telerehabilitation methods and mobile application from asynchronous telerehabilitation methods at home. These participants will be given an 8-week exercise program. The exercise program will consist of physical exercises (aerobic and strength exercises) along with breathing exercises and the patients will be evaluated before and after the treatment. After treatment programs, the functional capacity, performance, and hemodynamic parameters of the participants will be evaluated. Quality of life, physical activity level, anxiety-depression, and fatigue severity will also be evaluated with questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Synchronous telerehabilitation programme | Exercise program and educational program |
| OTHER | Asynchronous telerehabilitation programme | Exercise program educational program |
Timeline
- Start date
- 2021-09-25
- Primary completion
- 2022-08-05
- Completion
- 2022-09-07
- First posted
- 2022-01-25
- Last updated
- 2023-03-09
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05205434. Inclusion in this directory is not an endorsement.